Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Health & Fitness
Sports
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/b0/85/56/b0855646-586e-5f8c-3cfd-d38a93bdb709/mza_14317687522762424614.jpg/600x600bb.jpg
Decoded
Dr. Jurgi Camblong
4 episodes
1 week ago
A Conversation with Parminder Bhatia, Chief AI Officer, GE HealthCare After three episodes with leaders in oncology and medicine - Prof. Malapelle (International Society of Liquid Biopsy), Dr. David Rhew (Microsoft), and Dr. Pedram Razavi (MSK), Jurgi turns to the question everyone’s asking: How do we move from impressive demos to real impact at the bedside—at scale? In this episode, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Parminder “Parry” Bhatia, Chief AI Officer at GE ...
Show more...
Medicine
Technology,
Health & Fitness,
Science,
Life Sciences
RSS
All content for Decoded is the property of Dr. Jurgi Camblong and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A Conversation with Parminder Bhatia, Chief AI Officer, GE HealthCare After three episodes with leaders in oncology and medicine - Prof. Malapelle (International Society of Liquid Biopsy), Dr. David Rhew (Microsoft), and Dr. Pedram Razavi (MSK), Jurgi turns to the question everyone’s asking: How do we move from impressive demos to real impact at the bedside—at scale? In this episode, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Parminder “Parry” Bhatia, Chief AI Officer at GE ...
Show more...
Medicine
Technology,
Health & Fitness,
Science,
Life Sciences
Episodes (4/4)
Decoded
AI Adoption at Scale: Real-World Impact in Healthcare
A Conversation with Parminder Bhatia, Chief AI Officer, GE HealthCare After three episodes with leaders in oncology and medicine - Prof. Malapelle (International Society of Liquid Biopsy), Dr. David Rhew (Microsoft), and Dr. Pedram Razavi (MSK), Jurgi turns to the question everyone’s asking: How do we move from impressive demos to real impact at the bedside—at scale? In this episode, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Parminder “Parry” Bhatia, Chief AI Officer at GE ...
Show more...
2 weeks ago
31 minutes

Decoded
Rethinking Cancer Through AI and Precision Medicine with Dr. Pedram Razavi, Memorial Sloan Kettering Cancer Center
Cancer has been described for a long time, yet only now are we beginning to truly decode it. In this episode of Decoded, Dr. Jurgi Camblong, Founder of SOPHiA GENETICS, speaks with Dr. Pedram Razavi, Director of Liquid Biopsy and Cancer Genomics at Memorial Sloan Kettering Cancer Center. From the first historical mentions of tumors to today’s breakthroughs in precision oncology, Dr. Razavi shares how genomics, liquid biopsy, and AI are reshaping the way we detect, treat, and even thin...
Show more...
1 month ago
37 minutes

Decoded
Transforming Healthcare with Responsible AI: A Conversation with David Rhew, Microsoft’s Global Chief Medical Officer
In this episode of Decoded, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Dr. David Rhew, Global Chief Medical Officer at Microsoft and adjunct professor at Stanford University, to explore how responsible AI, multimodal data, and collective intelligence are reshaping global healthcare. From his early fascination with arcade games to his leadership at Microsoft, Dr. Rhew shares a unique journey that blends computer science, clinical practice, and visionary health technology. Toge...
Show more...
3 months ago
36 minutes

Decoded
Liquid Biopsy Decoded: Data, Diagnostics, and the Future of Cancer Care
How do we move from discovery to action in the fight against cancer? In this inaugural episode of the Decoded podcast, Dr. Jurgi Camblong speaks with Professor Umberto Malapelle, one of the leading voices in molecular diagnostics and liquid biopsy, to explore how precision data is reshaping the fight against cancer. Together, they decode the evolving role of pathology, tracing the shift from glass slides to genomic signals and the rise of liquid biopsy as a dynamic, non-invasive tool in ca...
Show more...
4 months ago
23 minutes

Decoded
A Conversation with Parminder Bhatia, Chief AI Officer, GE HealthCare After three episodes with leaders in oncology and medicine - Prof. Malapelle (International Society of Liquid Biopsy), Dr. David Rhew (Microsoft), and Dr. Pedram Razavi (MSK), Jurgi turns to the question everyone’s asking: How do we move from impressive demos to real impact at the bedside—at scale? In this episode, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Parminder “Parry” Bhatia, Chief AI Officer at GE ...